From Dailymail · · 2m
Breakthrough for lethal pancreatic cancer: Drug combo 'makes tumours disappear'
Drug combo for pancreatic cancer 'makes tumours disappear' in 1 in 12 patients, experts say.
In brief
Drug combo for pancreatic cancer 'makes tumours disappear' in 1 in 12 patients, experts say. Combination of Daraxonrasib and chemotherapy shrinks or erases pancreatic tumors in 60% of patients, with 1 in 12 seeing complete disappearance. Originally reported by Dailymail.
Breakthrough for pancreatic cancer
Doctors hailed a breakthrough in fighting pancreatic cancer after a new drug combination showed tumors shrinking or disappearing in clinical trials.
Drug combo shows promise
Daraxonrasib, when combined with chemotherapy, increased survival rates to 76.6% after one year compared to 45% with standard treatment alone.
Tumors disappear in 1 in 12 patients
In 18 months, 1 in 12 patients saw their tumors completely disappear after treatment.
Drug targets cancer growth
The drug locks onto the mutated KRAS gene, responsible for 90% of pancreatic tumors, to stop cancer cells from multiplying.
Survival rates improve
Over 76% of patients survived one year after treatment, compared to 45% with standard care.
Dr. Park's assessment
Dr. Wungki Park, an oncologist at Memorial Sloan Kettering, called the results the 'closest thing to a cure' for pancreatic cancer.
“This is the closest thing we've got to a cure. We have never seen so many patients whose cancer has spread respond completely to a drug.”
Pancreatic cancer statistics
11,500 people in the UK are diagnosed with pancreatic cancer yearly, with 10,200 dying from it.
Treatment challenges
Fewer than 5% of patients discontinued treatment due to side effects like rash, diarrhea, fatigue, and nausea.
Dr. Kara's call to action
Dr. Madina Kara urged the UK government to increase investment in pancreatic cancer research and fast-track new treatments.
“Half of people with pancreatic cancer die within three months of diagnosis and their loved ones would give anything to spend more precious time with them.”
The bottom line
Combination of Daraxonrasib and chemotherapy shrinks or erases pancreatic tumors in 60% of patients, with 1 in 12 seeing complete disappearance.
Read the TL;DR — this story on one card.



